PRIMARY STUDY
Cannabidiol inhibits methamphetamine-induced dopamine release via modulation of the DRD1-MeCP2-BDNF-TrkB signaling pathway
Key Findings: Resulting data suggests that CBD significantly inhibits methamphetamine-induced dopamine release.
Type of Study: Laboratory Study
Study Result: Positive
Research Location(s): China
Year of Pub: 2022
Cannabinoids Studied: Cannabidiol (CBD)
Phytocannabinoid Source: Unspecified
Chemotype: Chemotype III
Route of Administration: In vitro
Citation: Shen B, et al. Cannabidiol inhibits methamphetamine-induced dopamine release via modulation of the DRD1-MeCP2-BDNF-TrkB signaling pathway. Psychopharmacology (Berl). 2022; 239:1521-1537. doi: 10.1007/s00213-021-06051-y
Authors: Shen B, Zhang D, Zeng X, Guan L, Yang G, Liu L, Huang J, Li Y, Hong S, Li L
